Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01094730 · ClinicalTrials.gov registry record · NA

Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
185
Enrollment target
9
Study locations

NCT01094730 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 185 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (30% lower). The trial reports 9 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01094730, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
185 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to compare lens surface characteristics and comfort between an experimental contact lens and a marketed contact lens.

Conditions Studied

Interventions

  • DEVICE galyfilcon A prototype lens
  • DEVICE marketed galyfilcon A lens

Study Locations (9)

California

  • - Cupertino
  • - Huntington Beach
  • - Los Angeles
  • - Pismo Beach

Florida

  • - Jacksonville
  • - Orlando

Michigan

  • - East Lansing

Ohio

  • - Columbus

Texas

  • - Amarillo

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2010-02-01
Est. Completion 2010-04-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01094730

The ClinicalTrials.gov registry entry for NCT01094730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (30% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which galyfilcon A prototype lens is the first listed.

NCT01094730 reports 9 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT01094730 about?

NCT01094730 is a clinical study titled "Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens". The purpose of this study is to compare lens surface characteristics and comfort between an experimental contact lens and a marketed contact lens.

What is the current status of trial NCT01094730?

This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2010-02-01. Estimated completion is 2010-04-01.

What conditions does trial NCT01094730 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01094730?

The interventions under investigation include: galyfilcon A prototype lens (DEVICE), marketed galyfilcon A lens (DEVICE).

Who is sponsoring clinical trial NCT01094730?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01094730 being conducted?

This trial has 9 study locations across California, Florida, Michigan, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.